(NASDAQ:RXST) Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in RxSight between November 7, 2024 and July 8, 2025 and...
Related Questions
What is the current short interest and options activity on RXST following the lawsuit reminder, and are there any notable shifts in trader positioning?
How might this pending class action affect RXST's liquidity, institutional ownership, and valuation relative to peers in the ophthalmic device sector?
How likely is a settlement or court ruling before the September 22, 2025 lead plaintiff deadline and what price impact could that have?